Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Ciclosporin
Vevizye
Not routinely available
SMC (SMC2873)
21/01/2026
Indication
Treatment of moderate to severe dry eye disease (keratoconjunctivitis sicca) in adult patients, which has not improved despite treatment with tear substitutes. SMC restriction: severe keratitis in adult patients with dry eye disease.
Therapeutic Area
Eye
Status Description
Not Routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
1mg/mL eye drops, solution in multidose container
Comments
Link to Advice
Advice Published
19/01/2026
SMC Submission Type
Abbreviated
SMC Status
Restricted